...
首页> 外文期刊>Thrombosis Research: An International Journal on Vascular Obstruction, Hemorrhage and Hemostasis >Assessment of in vitro-generated platelet microparticles using a modified flow cytometric strategy.
【24h】

Assessment of in vitro-generated platelet microparticles using a modified flow cytometric strategy.

机译:使用改良的流式细胞术策略评估体外产生的血小板微粒。

获取原文
获取原文并翻译 | 示例

摘要

Quantification of platelet microparticles (PMPs) may be a useful marker for the detection of in vivo platelet activation. Optimisation of flow cytometric methods for detection and quantification of PMPs has not been systemically evaluated. This study reports the optimisation of flow cytometric procedures for the detection of PMPs, the determination of limits of size detection using microbeads, and the characterisation of PMP generation by in vitro activation of platelets using collagen and adenosine 5' diphosphate (ADP). Fluorescent and plain microbeads proved useful for defining the limits of the flow cytometer in detecting PMPs. A systematic calibration of the forward scatter (FS) threshold parameter (size) of the flow cytometer using microbeads allowed for the detection of very small particles (down to 0.1 microm diameter). PMPs generated in vitro using ADP and collagen were reliably detected by flow cytometry using monoclonal antibodies (MAb) directed towards platelet surface membrane glycoproteins (Gp). The PMP events were detected in the FS low (i.e., small size events) and fluorescence (FL) high (i.e., platelet Gp MAb-labelled events) region. PMPs of different size profiles were observed for each of the agonists. Flow cytometry can be used as a tool in the assessment of PMPs. As detection of particles of this type is at the limit of resolution of flow cytometers, careful attention is required with the choice of platelet-specific MAb, isotype control, and optimisation of procedure setup and performance.
机译:血小板微粒(PMP)的定量可能是检测体内血小板活化的有用标记。尚未系统评估用于检测和定量PMP的流式细胞术方法的优化。这项研究报告了用于检测PMP的流式细胞术程序的优化,使用微珠确定大小检测的极限以及通过使用胶原蛋白和5'二磷酸腺苷(ADP)体外活化血小板来表征PMP的特征。事实证明,荧光微珠和普通微珠可用于确定流式细胞仪检测PMP的极限。使用微珠对流式细胞仪的前向散射(FS)阈值参数(大小)进行系统校准,可检测非常小的颗粒(直径小至0.1微米)。使用针对血小板表面膜糖蛋白(Gp)的单克隆抗体(MAb),通过流式细胞术可靠地检测了使用ADP和胶原蛋白体外产生的PMP。在FS低(即小尺寸事件)和荧光(FL)高(即血小板Gp MAb标记的事件)区域中检测到PMP事件。对于每种激动剂,观察到不同大小的PMP。流式细胞术可以用作评估PMP的工具。由于这种类型颗粒的检测处于流式细胞仪分辨率的极限,因此需要特别注意血小板特异性单克隆抗体的选择,同种型控制以及程序设置和性能的优化。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号